Plasma Concentration of Biological Markers in Placental Abruption
Sponsor: University of Arkansas
Terminated
IRB approval expired; failure to submit continuing review in time. Will re-open once IRB approval is reinstated.
Listed as NCT03782168, this observational or N/A phase trial focuses on Abruptio Placentae and remains terminated or withdrawn. Sponsored by University of Arkansas, it has been updated 15 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
15 versions recorded-
Oct 2024 — Present [monthly]
Terminated
-
Sep 2024 — Oct 2024 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
Status: Suspended → Terminated
-
Nov 2021 — Dec 2021 [monthly]
Suspended
Status: Active Not Recruiting → Suspended
▶ Show 10 earlier versions
-
Sep 2021 — Nov 2021 [monthly]
Active Not Recruiting
-
May 2021 — Sep 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — May 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Recruiting
-
Sep 2020 — Oct 2020 [monthly]
Recruiting
-
Jun 2020 — Sep 2020 [monthly]
Recruiting
-
Jun 2019 — Jun 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Feb 2019 — Jun 2019 [monthly]
Not Yet Recruiting
-
Jan 2019 — Feb 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Arkansas
For direct contact, visit the study record on ClinicalTrials.gov .